School of Medicine
Showing 681-700 of 739 Results
-
Jia-Horung Hung, MD, PhD
Clinical Instructor, Ophthalmology
BioDr. Hung is a fellowship-trained ophthalmologist, practicing at the Byers Eye Institute, and also a clinical instructor in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Hung specializes in diagnosing and treating ocular inflammatory diseases, such as uveitis, iridocyclitis, and scleritis, as well as retinal vascular diseases, including age-related macular degeneration and diabetic retinopathy.
Dr. Hung’s research interests include ocular inflammation, infections, hereditary ocular inflammatory diseases, and novel approaches in managing ocular inflammatory diseases. His research has advanced screening, diagnostics, and treatment for patients with uveitis, lens disorders, retinal diseases, glaucoma, and rare ocular conditions. Dr. Hung’s most recent research explores the use of artificial intelligence (AI) to improve the identification of ocular inflammatory diseases.
Dr. Hung has published his work in major national and international peer-reviewed journals, including American Journal of Ophthalmology, British Journal of Ophthalmology, RETINA, Clinical & Experimental Ophthalmology, and Survey of Ophthalmology. He has presented at national and international conferences on the use of technology in uveitis management.
Dr. Hung is a member of many professional organizations, including the American Society of Retina Specialists, the International Ocular Inflammation Society, the Foster Ocular Immunology Society, and the European Society of Retina Specialists. -
Matthew Hung
Assistant Professor of Radiology (Interventional Radiology)
BioMatthew Hung, M.D. is a radiologist specializing in Vascular & Interventional Radiology. Dr. Hung earned his M.D. from the David Geffen School of Medicine at UCLA in 2018 and was a recipient of the David Geffen Medical Scholarship. He completed his Transitional Year internship at Memorial Sloan Kettering Cancer Center in 2019. Following completion of his integrated Interventional Radiology/Diagnostic Radiology residency at the Hospital of the University of Pennsylvania in 2024, he joined Stanford University Medical Center where he is currently a clinical assistant professor of radiology.
Dr. Hung specializes in lymphatic interventions, adrenal vein sampling, interventional oncology (minimally invasive cancer treatments including ablation, chemoembolization and radioembolization), the treatment of cirrhosis (end-stage liver disease) and portal hypertension, as well as therapies for uterine fibroids (uterine artery embolization) and benign prostatic hyperplasia (prostate artery embolization).
Dr. Hung is active in clinical research and his research interests include the above clinical domains as well as topics in general interventional radiology ranging from complex drainage to venous access device infections. He has published in peer-reviewed journals such as the Journal of Vascular and Interventional Radiology (JVIR) and presented at several professional society meetings, including the Society of Interventional Radiology (SIR). He was also a recipient of the SIR Radiology Resident Research Grant, investigating quality of life and muscle wasting in patients with refractory ascites. -
Sharon Wei Hung
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioSharon Hung MD, FACP is a board-certified Internal Medicine physician practicing at the Stanford Internal Medicine Clinic in Santa Clara. She earned her MD from the Northwestern University Feinberg School of Medicine and completed her internal medicine residency at Cedars-Sinai Medical Center. Prior to joining Stanford, she served on the faculty at the University of Arizona College of Medicine.
Dr. Hung is the Director of Women’s Health for the Department of Primary Care and Population Health. In this role, she served as course director for Stanford CME’s Women’s Health Conference and continues to co-direct the annual Stanford CME Menopause and Healthy Aging Conference. She also hosts the Stanford CME/YouTube Women’s Health Vodcast, where she interviews leading experts and explores timely, clinically relevant topics in women’s health.
Her scholarly interests include breast cancer screening, steatotic liver disease, osteoporosis, and weight gain during the perimenopausal period. Clinically, she is dedicated to preventive medicine and the management of chronic conditions such as pre-diabetes, obesity and metabolic syndrome, as well as guiding women through the perimenopausal transition. Dr. Hung also leads bi-monthly group patient visits focused on the prevention and treatment of osteoporosis. She is passionate about inspiring trainees and works with both Stanford Internal Medicine residents and Physician Assistant students.
She is conversational in both Spanish and Mandarin. -
Jennifer L. Hunter, PA-C
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioJennifer Hunter, PA-C is the Lead Advanced Practice Provider (APP) for the Emergency Department & Clinical Decision Unit (CDU) with experience in Adult Congenital Heart Disease (ACHD) and over 10 years of experience in Emergency Medicine. She is also a Clinical Assistant Professor and Educator-4-Care (E4C) at the Stanford School of Medicine & Masters of Science in PA Studies Program.
-
Dong Gi Hur
Affiliate, Department Funds
Resident in SurgeryBioDong Hur is a Stanford Medical Student applying into General Surgery, with a keen interest in using big data analysis and machine learning to address healthcare disparities. His research focuses on trauma center access and the use of circulating tumor DNA for the early detection of soft tissue sarcoma. Outside of medicine, Dong Hur enjoys hiking, playing pickleball, and camping
-
Sohail Z Husain
Chambers-Okamura Endowed Professor of Pediatric Gastroenterology
Current Research and Scholarly InterestsMy research delves into three broad areas of the exocrine pancreas: (1) The crucial signaling pathways that initiate and transduce pancreatitis; (2) the factors that turn on pancreatic regeneration and recovery after pancreatic injury; and (3) the mechanisms underlying drug-induced pancreatitis.
